Acknowledgements

The report was drafted by Dr Pavana Murthy, Dr Giridhara Babu, Mr Himanshu Sekhar Pradhan,
Dr Ramesh Krishnamurthy and further peer reviewed by the experts who participated in
the workshop.
Contents
Abbreviations i

Executive summary 1

Key recommendations 2

1 Background 3

1.1 Prioritization process 4

1.2 Formation of the working group 4

2 Proceedings of the workshop – Day 1 5

2.1 Inauguration 5

2.2 Session 1: Trends in surveillance systems and current status of IDSP 6

2.3 Sessions 2 & 3: Disease prioritization 7

3 Proceedings of the workshop – Day 2 9

3.1 Session 4: Findings of group work and panel reflections 9

3.2 Session 5: Data collection tools for IDSP 14

3.3 Session 6: Information and communication technology for IDSP 15

3.4 Session 7: Recommendations and conclusions 17

Annexures 19

Annexure 1: Agenda 19

Annexure 2: List of participants 22

Abbreviations
AES acute encephalitis syndrome

AFI acute febrile illness

ANM auxillary nurse midwife

ARI acute respiratory infection

CCHF Crimean-Congo haemorrhagic fever

CDC India US Centers for Disease Control and Prevention – India Country Office

CHC community health centre

CSU central surveillance unit

DDG Deputy Director General

DGHS Director General of Health Services

DHS Director Health Services

DSU district surveillance unit

FA factor analysis

GHSA Global Health Security Agenda

HIS Health Information System

HO Health Officer

ICMR Indian Council of Medical Research

ICT information and communication technology

IDSP Integrated Disease Surveillance Project

IHR International Health Regulations

ILI influenza-like illness

IT information technology

JE Japanese encephalitis

JMM Joint Monitoring Mission

JS Joint Secretary

KFD Kyasanur Forest Disease

i
L Form Laboratory Surveillance Form

MCI Medical Council of India

MoHFW Ministry of Health & Family Welfare

NCD noncommunicable disease

NCDC National Centre for Disease Control

NHM National Health Mission

NPCDCS National Programme for Prevention and Control of Cancers, Diabetes,

Cardiovascular Disease and Stroke

NPO National Programme Officer

NVBDCP National Vector Borne Disease Control Programme

P Form Presumptive Surveillance Form

PHFI Public Health Foundation of India

RNTCP Revised National Tuberculosis Control Programme

S Form Syndromic Surveillance Form

SARS severe acute respiratory syndrome

SHOC Strategic Health Operations Centre

SSU state surveillance unit

WCO India WHO Country Office for India

WHO World Health Organization

WR WHO Representative

ii
Executive summary
In keeping with one of the key recommendations of the Joint Monitoring Mission (JMM) of
2015, the Integrated Disease Surveillance Project (IDSP) administered a reprioritization
exercise to review the relevance and importance of all diseases and conditions under IDSP.
JMM strongly recommended the redesign of the IDSP surveillance system with
reprioritization of the diseases/disease groups. This had to be guided by assessing the need
for collecting more epidemiological data for action, especially for the priority diseases, and
redefining the required surveillance deliverables.
The purpose of the reprioritization exercise was to ensure the best use of limited human and
financial resources for disease surveillance, taking into account changing demographic and
epidemiological conditions. The exercise was essential to ensure that both planning and
resource allocation were rational, explicit and transparent.
The objectives of the exercise were to:
 Review the relevance of the list of priority diseases for surveillance under IDSP;
 Strengthen IDSP in its resource allocation for disease surveillance and response;
and
 Focus on the diseases that affect the majority of the population and have more
severity and adverse sequels.
The reprioritization exercise was organized in a systematic manner. Firstly, an initial list of
46 diseases that included zoonotic, food borne, water borne, vector borne and vaccine
preventable diseases were considered based on key parameters such as disease burden,
severity, epidemic potential, health gain, socioeconomic impact and international regulations.
Subsequently, a suggestive list of 32 diseases was considered in consultation with the
National Centre for Disease Control (NCDC).
The next step was to assemble an expert group consisting of disease-specific specialists,
statisticians, laboratory specialists and public health professionals at all levels and from
different surveillance and control programmes to include representation from the Centre,
states, academia, World Health Organization (WHO), US Centers for Disease Control and
Prevention (CDC) and other health and development partners through a workshop. This
workshop was organized by WHO in collaboration with NCDC, Ministry of Health & Family
Welfare (MoHFW), Government of India (GoI) and CDC on 6–7 December 2016 in
New Delhi.
During the workshop, the experts were divided into eight groups and were provided with a
disease-scoring sheet. Each group was provided with a list of 32 diseases and basic disease
profile for each disease. A group chair and rapporteur were identified for each group and
they facilitated scoring of all the 32 diseases. The scoring for each disease was marked on
the scoring sheet through a consensus process within each group. The scoring sheet
contained 11 scoring dimensions to prioritize each disease. The scoring dimensions included
present burden of diseases, severity, mortality, epidemic potential, socioeconomic impact,
preventability, treatability, relevance to IHR, international resolutions, relevance to regional
control and relevance to control within the state.
At the end of the reprioritization exercise, the scores from all groups for all diseases were
weighed and averaged to create a prioritized diseases list. The prioritized diseases list was

1
further validated by statistical experts and scores were further analysed using factor
analysis, which resulted in identification of 32 diseases/conditions reprioritized in a rank
order of importance (disease list is reflected in the report). Apart from the 32 diseases, there
was consensus among groups to also include human rabies into the list.
Updating IDSP’s Integrated Disease Surveillance, and best practices from the Bruhat
Bengaluru Mahanagara Palika (BBMP) experiences in software for IDSP were discussed
during the meeting.

Key recommendations
Following are the key recommendations of the workshop:
 As a first step, following this prioritization exercise, IDSP needs to update the
following components for all 32 prioritized diseases: (i) case definitions; (ii) type of
surveillance to be implemented for each of the prioritized diseases; (iii) minimum data
sets and data collection standards for each prioritized disease. It also needs to make
all relevant changes to the reporting forms to reflect the amendments.
 An expert consultation needs to be organized for updating data capturing tools (S, P
and L Forms) and minimum data sets for the diseases including finalization of the
formats for surveillance.
 IDSP to advise all state surveillance units (SSUs) to conduct similar reprioritization
exercises to include diseases of importance at the state level.
 IDSP’s information and communication technology (ICT) platform and information
management needs to be upgraded to conform to the current standards. A
comprehensive ICT and Information Management Master Plan Document needs to
be developed and maintained.
 A comprehensive Operational Document must be developed to implement the
aforementioned Master Plan with clearly articulated timelines, roles and
responsibilities.
 Updated Data-sharing agreements need to be put in place between various parties,
including states, local governments and the private sector
 As part of a national integrated disease surveillance effort, IDSP needs to identify all
relevant disease surveillance aggregate data from specialized disease surveillance
programmes for potential inclusion under a common integrated disease surveillance
“dash board” that will be administered by IDSP.

2
1 Background
Disease surveillance is a critical component of the health system. A functional surveillance
system not only provides the information for action on priority communicable diseases, but
also plays a crucial role in public health decision-making. Surveillance systems are usually
developed over time, with new diseases being added and a few being removed. A national
surveillance system should cover the diseases of public health importance that affect the
majority of the population with severe and adverse consequences.
Prioritization of diseases is an integral, periodic process to strengthen a national surveillance
system for communicable diseases and can be used as an aid in making decisions about
resource allocation. In many surveillance systems, data are collected which never result in
public health action, and new threats are considered insufficiently or not at all. As public
health risks change over time, prioritization of diseases for surveillance should be reviewed
periodically.
The Integrated Disease Surveillance Programme (IDSP) in India was launched in 2004 to
detect and respond to disease outbreaks. It became a National Programme during the
Twelfth Five-Year Plan and functions under the umbrella of the National Health Mission.
The first disease prioritization for IDSP was done in 2004 and subsequently in 2009.
Currently, 18 disease conditions are being monitored under IDSP. In 2015, the Joint
Monitoring Mission (JMM) for IDSP strongly recommended redesign of the IDSP surveillance
system with reprioritization of the diseases/disease groups. In the recent past, India has
recognized the geographic expansion of diseases such as scrub typhus, Crimean-Congo
haemorrhagic fever (CCHF) and Japanese encephalitis (JE). Hence, there is a need to
relook at disease prioritization and investments for enhancing the surveillance mechanisms.
Considering all these aspects for strengthening the IDSP, World Health Organization
Country Office for India (WCO India) jointly with National Centre for Disease Control (NCDC)
of the Ministry of Health and Family Welfare (MoHFW), US Centers for Disease Control and
Prevention India Country Office (CDC India) initiated the process for reprioritization of
diseases under IDSP. As a preparatory process for the disease reprioritization exercise, a
series of activities as detailed below were undertaken ahead of this exercise. The prioritizing
of diseases for surveillance involved complex value judgments, such as the relative
importance of early detection of a highly infectious disease compared with monitoring
endemic, common, but less severe diseases. Hence, the methodology was aimed at a
process that would be transparent and acceptable to most stakeholders and implementers of
the surveillance system. It attempted to combine quantifiable epidemiological, clinical and
financial data with interpretive assessments based on consensus views of informed
participants.
Ideally, prioritization should be based on scientific evidence. However, such evidence is
frequently unavailable and there is a particular deficiency in data on the effectiveness and
outcomes of surveillance systems. As the situations involved insufficient, inadequate,
contradictory or even non-existent scientific information, consensus methods such as the
Delphi method were considered a valid approach, which provided a structure and process to
harness the insight of appropriate experts to enable decisions to be made avoiding personal
and political influence and allowing individuals to change their opinion in light of the group
response.

3
1.1 Prioritization process
This prioritization process consisted of the following steps:
 Formulation of a list of diseases and criteria to include/exclude diseases for
surveillance
 Formulation of a scoring sheet for prioritizing the diseases against the criteria
 Discussion of the proposed criteria and disease list by participants in the prioritization
exercise
 Expression of averaged score of the subject matter experts (based on individual
opinions of participants) through scoring the diseases against the criteria
 Collation and summary (using statistical parameters) of the scoring, and assessment
of agreement
 Feedback of the individual and group rankings to the participants and discussion of
the results
 Weighting and revision of the prioritized list of diseases
 Sharing the finalized list of prioritized diseases.

1.2 Formation of the working group

A working group was formed with representation from MoHFW, NCDC, IDSP, Public Health
Foundation of India (PHFI) and medical colleges. WHO guided the disease reprioritization
process. A consultative process with IDSP ensured finalization of case definition of diseases.
There were two technical consultations held for finalization of cases definitions of various
diseases (likely to be considered for inclusion under IDSP) including emerging and
remerging diseases under various categories such as zoonotic, vaccine preventable, vector
borne, food and water borne, as well as diseases covered under International Health
Regulation (IHR).
Considering different parameters such as disease burden, epidemic potential, health gain,
socioeconomic impact, etc. a list of 46 diseases was prepared. Further, through a
consultative process with NCDC, a suggestive list of 32 diseases was generated for
consideration under the disease prioritization exercise. However, the experts were provided
the flexibility to include or exclude diseases during the disease reprioritization exercise.
Disease information sheets were prepared and used during the prioritization exercise to
assist the experts.
Formation of experts: Experts from the various fields were assembled consisting of
disease specific experts, statisticians, IT, laboratory and public health professionals.
Over 80 subject matter experts representing states, the Centre, academia, WHO, CDC and
other health and development partners participated in the workshop. The list of participants
is at Annex 2.

4
2 Proceedings of the workshop – Day 1
The two-day National Workshop on Reprioritization of Diseases was held on on 6–7
December 2016 to reprioritize the diseases/disease groups under IDSP and standardize
case data elements, data collection methods and information technology (IT) tools.

2.1 Inauguration
In his welcome address, Dr S. Venkatesh,
Director, NCDC highlighted the achievements and
initiatives taken by NCDC and IDSP over the
years. He said that the disease reprioritization
workshop would help in making decisions for
resource allocation under IDSP as well as in
effective execution of the programme and
standardization of data elements, data
collection methods and IT tools.
In his address, Dr A.K. Gadpayle, Additional Director General of Health Services
(Addl DGHS), MoHFW emphasized the need for reprioritization of diseases under
surveillance in IDSP in view of the recent threats posed due to emerging and re-emerging of
diseases.
Speaking on the occasion, Mr Lav Aggarwal,
Joint Secretary (JS), MoHFW stressed that
IDSP should be the mother of all monitoring
mechanisms for various health programmes
and that there is a need for renewed focus
on IDSP. He stressed that appropriate
strategies needed to be developed for
capturing disease data from urban areas as
well as from the private sector. He
emphasized the use of latest IT tools to
make meaningful interventions from the
surveillance data collected in the field.
Dr Henk Bekedam, WHO Representative
(WR) to India emphasized the need to
equip India’s surveillance system well in
view of emerging threats like severe acute
respiratory syndrome (SARS), Ebola, Zika,
etc. Further, he emphasized the need for
strengthening the laboratory component of
IDSP and use of IT for real-time web-
based reporting, collaboration of the health
department with the agriculture sector for
zoonotic diseases and strengthening of
public health cadres for enhancing the surveillance system in India.

5
 Dr B.D. Athani, Special DGHS, MoHFW
outlined establishing linkages with other
communicable disease programmes for
accessing the data from them and the need to
establish linkages with the private sector for
receiving disease related data.

Reflecting MoHFW’s commitment to

strengthening the IDSP, Professor
(Dr) Jagdish Prasad, DGHS, MoHFW
emphasized the need to urgently fill the
critical vacant positions of epidemiologists,
microbiologists and entomologists under
IDSP and train them for strengthening the
surveillance programme. He further
emphasized on strengthening IDSP
laboratories, its infrastructure, surveillance as
well as augmenting the implementing of IDSP.

2.2 Session 1: Trends in surveillance systems and current status

of IDSP
Session Chair : Dr B.D. Athani, Special DGHS, MoHFW
Co-chairs : Dr Gadpayle, Addl. DGHS, MoHFW
Dr K.K. Aggarwal, President-elect, Indian Medical Association
Four presentations were made in this session.
 Key functions, structure and data management aspects of IDSP were covered by
Dr Pradeep Khasnobis, National Programme Officer (NPO), IDSP, NCDC.
Achievements as well as constraints of IDSP were highlighted. Areas that need
focused interventions were: monitoring of
IDSP by State Health Secretary/Mission
Director, National Health Mission
(NHM)/Director Health Services (DHS);
enhancing coordination between DHS and
Director Medical Education; recording of
diagnosis by doctors in the OPD register
in major hospitals; participation of the
private sector in data reporting;
functioning of identified district public

6
 health laboratories under IDSP; strengthening urban surveillance; sending samples
to the laboratory in all outbreaks; and convergence with other national health
programmes and ICMR.
 Dr Sameer Sodha, CDC Resident Advisor, Epidemic Intelligence Service
Programme, India highlighted two laboratory-based surveillance projects with the
Global Health Security Agenda (GHSA) – acute febrile illness (AFI) surveillance led
by Manipal Centre for Virus Research and acute encephalitis syndrome (AES)
surveillance led by National Institute of Mental Health and Neurosciences. A number
of recommendations were made, such as use of laboratory-based surveillance to
monitor trends, detect outbreaks and guide laboratory strengthening; evaluate rapid
diagnostic tests for leading pathogens for potential sub-district/district level use,
unifying data management of surveillance systems for the National Vector Borne
Disease Control Programme (NVBDCP), IDSP, and Child Health Division; ensuring
same case definitions (e.g. meningitis versus AES) and encouraging increased
laboratory testing at district level.
 Dr Vason Pinyowiwat, Technical Officer, WHO Regional Office for South-East Asia
highlighted surveillance models of Sri Lanka and Thailand, describing the
organization of the surveillance system, disease notification system, data collection
and reporting mechanisms of Sri Lanka as well as organization of surveillance
system, list of diseases under surveillance and morbidity notification of Thailand.
 Dr Nishant Kumar, Assistant Director, IDSP, NCDC brought out that initially 13 core
diseases and conditions were under surveillance in IDSP. The disease list was
revised in 2009, giving more focus on outbreak-prone diseases with 18 disease
conditions. Evolution of data reporting formats as well as data management aspects
of IDSP were highlighted in his presentation. Preparatory activities of prioritization
exercises such as two consultations were held for finalization of case definitions of
diseases under various categories such as zoonotic, vaccine preventable, vector
borne, food and water borne.
 Dr Sanket Vasant Kulkarni, Assistant Director, IDSP, NCDC discussed state specific
diseases being reported under IDSP. Additional diseases under consideration for
IDSP such as scrub typhus, anthrax, Kyasanur Forest Disease (KFD), CCHF and
mumps were discussed.
 Dr K. K. Aggarwal, President-elect, Indian Medical Association, suggested to make
use of Medical Council of India’s (MCI) regulations, which mandate reporting of
diseases by registered medical practitioners. He stressed that Revised National
Tuberculosis Control Programme (RNTCP)’s methods for enhancing reporting from
the private sector should be adapted for notification/reporting of other diseases.

2.3 Sessions 2 and 3: Disease prioritization

Session Chair : Dr S. Venkatesh, Director, NCDC
Co-chair : Dr Ramesh Krishnamurthy, Senior Advisor, Department of Information,
Evidence and Research, Health Systems and Innovation Cluster, WHO

 Dr Giridhara R. Babu, Additional Professor, Indian Institute of Public Health,

Bengaluru described the methodology for scoring the diseases. The scoring sheet
contained 11 scoring dimensions to prioritize each disease. These scoring
dimensions included the present burden of disease, severity, mortality, epidemic

7
 potential, socioeconomic impact,
preventability, treatability, relevance to
IHR, international resolutions, relevance
to regional control and relevant
importance to the state. A total of 32
diseases were considered for scoring.
 During the discussion, Dr Venkatesh
stressed that numbers alone could not
decide the epidemic potential of the
disease and that even a single case of
some diseases could equate to an epidemic.
 Discussions were held in eight groups. Disease scoring sheets and disease
information sheets were provided to each groups. These groups scored all the
32 diseases through a consensus process within each group. The scores from all
groups for all diseases were weighed and averaged, resulting in a prioritized
diseases list, which was presented during Day 2 of the workshop.

8
3 Proceedings of the workshop – Day 2
3.1 Session 4: Findings of group work and panel reflections
Session Chair : Dr P.L. Joshi, ex. Director, NVBDCP
Co-chairs : Dr D.C.S. Reddy, ex-Professor and Head of the Department, Preventive
and Social Medicine, Institute of Medical Sciences, Banaras Hindu
University
Dr Pavana Murthy, National Professional Officer, Surveillance and
Response, WHO Country Office for India

3.1.1 Summary of feedback

Summary of feedback of the group work is as follows:
 There should be a national core list of diseases with state specific amendments
 Acute respiratory infection (ARI) and influenza-like illness (ILI) need to be segregated
 “Fever of unknown origin” to be replaced with “fever” more than 7 days duration
 Acute diarrhoeal diseases to be written as “excluding cholera”
 Rickettsial disease, acute febrile illness (AFI) filariasis, leishmaniasis, poisoning,
burns, road accidents, snake bite, dog bite and West Nile Fever should be included
in the IDSP disease list
 Small pox to be removed from the IDSP disease list
 Death can be recorded in Presumptive Surveillance Form (P Form)
 Viral hepatitis B & C maybe included in Laboratory Surveillance Form (L Form)
 Reduce duplication of data collection
 Reduce number of diseases in P Form
 Forms require streamlining
 As disease priority differs from state to state, regional priority should be given
importance
 Response components should be integrated with surveillance
 Capacity building is needed on data analysis.
Dr Mohammad Shaukat, Deputy Director General (DDG), Noncommunicable Diseases
(NCDs), MoHFW, highlighted the issues for and challenges to NCD surveillance and
monitoring. Four common NCDs – cardiovascular diseases, diabetes, cancers and chronic
respiratory diseases accounted for about 55% of premature mortality in the age group of
30–69 years. The National Programme for Prevention and Control of Cancers, Diabetes,
Cardiovascular Disease and Stroke (NPCDCS) focused on the early screening, diagnosis
and treatment by NCD cells through community health centres (CHCs) at the district level.
The NPCDCS aimed at the integration of NCD interventions within the NHM framework for
optimization of scarce resources, provision of seamless services to patients as also for
ensuring long term sustainability of interventions.
The NCD programme has developed a recording and reporting mechanism to monitor the
key interventions outlined in strategies of the programme. The information is compiled from
NCD clinics located at CHC and district levels. In a limited resource setting, IDSP provides a
unique opportunity for surveillance and monitoring of key NCD indicators required to guide

9
the programme. There is a need to debate upon the inclusion of key indicators in the IDSP
dashboard with a decision on the frequency of data collection on such indicators.
Dr Pavana Murthy, National Professional Officer, Surveillance and Response, WHO Country
Office for India discussed findings of the group work. He demonstrated the data analysis
procedure and sample data analysis sheet. The scores from all groups for all diseases were
averaged, which resulted in a preliminary prioritized diseases list of
32 disease conditions in a rank order of importance.

There was further validation by statistical experts using factor analysis (FA), which reduced
the voluminous data by shrinking it to a smaller data set that was more manageable and
more understandable. Finally, range and rank were calculated for each disease loading by
the standard range formula and by using the rank function of excel.
Tables 1 and 2 give the final disease/syndrome lists by ranking.
Table1: Final list of disease/syndrome after factor analysis

Rank Final list of Syndrome/ Pathogens

diseases after disease
factor analysis

1 Influenza-like illness Syndrome Influenza A/H1N1pdm09, influenza

A/H3N2, influenza B, respiratory
syncytial virus A & B,
metapneumovirus,
parainfluenzavirus1–4, rhinovirus,
adenovirus

2 Severe acute Syndrome Influenza A/H1N1pdm09, influenza

respiratory infection A/H3N2, Influenza B, respiratory
syncytial virus A & B,
metapneumovirus,
parainfluenzavirus1-4, rhinovirus,
adenovirus, corona virus, bocavirus

3 Dengue Disease Dengue viruses (1,2,3 and 4)

4 Dysentery Syndrome Entamoeba histolytica and shigella

(including sub types)

5 Zika virus disease Disease Zika virus

6 Acute hemorrhagic Syndrome Dengue viruses, nairovirus (CCHF

fever virus), Ebola virus, West Nile virus,
arbovirus (yellow fever virus)

7 Acute viral hepatitis Syndrome Hepatitis virus A, B, C, D and E

Yellow fever virus

10
8 Acute diarrhoeal Syndrome Viruses: Rotavirus, adenoviruses,
disease (except coronaviruses, enteroviruses
cholera)
Bacteria: Enterotoxigenic E. coli,
shigella, Campylobacter Jejuni,
Salmonella
Others: Entamoeba histolytica,
giardiasis, trichuriasis, cryptosporidium

9 Chikungunya Disease Chikungunya virus

10 Chicken Pox Disease Varicella zoster

(Varicella Zoster)

11 Fever more than 7 Syndrome Dengue, Chikungunya, Malaria,

days duration Leptospirosis, Scrub typhus, Zika and
others

12 Malaria Disease Plasmodium falciparum, Plasmodium

vivax, Plasmodium ovale and
Plasmodium malariae

13 Scrub typhus Disease Orientia tsutsugamushi

14 Cholera Disease Vibrio cholerae O1

15 Smallpox Disease Variola virus

16 Enteric fever Disease Salmonella typhi, Salmonella paratyphi

A, Salmonella paratyphi B, Salmonella
paratyphi C

17 Acute flaccid Syndrome: Poliovirus (type 1, type 2 and type 3)

paralysis Enterovirus, Coxsackie virus and
DD;
echovirus serotypes
Poliomyelitis,
Gullian Barre Herpesviridae; Japanese encephalitis
Syndrome, virus
Transverse
myelitis

18 Measles Disease Rubeola virus

19 Acute encephalitis Syndrome Serum: JE, Scrub typhus, West Nile

syndrome Fever,
Cerebrospinal Fluid: Enteroviruses,
herpes, tuberculosis, Staphylococcus
pneumoniae, H influenza and Nisseria

11
20 Meningitis Syndrome Neisseria meningitidis

21 Yellow fever Disease Arbovirus

22 Rubella Disease Rubella virus

23 Kyasanur Forest Disease KFD virus

Disease (KFD)

24 Mumps Disease Myxovirus parotiditis

25 Anthrax Disease Bacillus anthracis

26 Crimean-Congo Disease Nairovirus

hemorrhagic fever
(CCHF)

27 Leptospirosis Disease Spirochetes of the genus Leptospira

28 Plague Disease Yersinia pestis

29 Brucellosis Disease Brucella abortus, Brucella melitensis

and Brucella suis

30 Pertussis Disease Bordetella pertussis and Bordetella

parapertussis

31 Diphtheria Disease Corynebacterium diphtheriae

32 Tetanus Disease Clostridium tetani

*Apart from the 32 diseases, there was consensus among the experts to also include human rabies
into the list.

12
Table 2: Priority syndromes/diseases for Integrated Disease Surveillance
Programme – 2017

Epidemic prone Syndrome/diseases Other major

syndrome/diseases targeted for eradication syndrome/diseases, events
or elimination or conditions of public
health importance

Acute haemorrhagic fever

Chikungunya Acute flaccid paralysis Acute viral hepatitis
Cholera Acute diarrhoeal
disease (except
Dengue
cholera)
Dysentery
Fever more than 7 days
Measles* duration
Meningitis Malaria
Plague Scrub typhus
ILI Anthrax
SARI Kyasanur Forest
Enteric fever Disease (KFD)

Chicken pox Crimean-Congo

hemorrhagic fever
Rubella (CCHF)
Mumps Leptospirosis
Pertussis Brucellosis
Diphtheria Tetanus
Diseases or events of international concern

Yellow fever

Human influenza due to a new subtype1

*Targeted for
elimination SARS1, Smallpox1

Poliomyelitis1
Zika virus disease
Any public health event of international or national
concern (infectious, zoonotic, food borne, chemical,
radio nuclear, or due to an unknown condition

1Disease specified by IHR (2005) for immediate notification

13
3.1.2 Limitations of the disease prioritization
This exercise focused only on ranking exercises conducted for diseases under the purview
of IDSP. However, quality assurance measures were put in place to mitigate any potential
bias. The groups used their own assessment tools to provide their view as a consensus in
terms of the relative importance of each domain in the scoring sheet for all diseases.
Further, use of a single checklist enabled comparisons to be made across all the groups
based on the principles of validity and reliability, regardless of the precise scoring criteria.

3.2 Session 5: Data collection tools for IDSP

Session Chair : Dr Sujeet Kumar Singh, DDG, Mental Health & International Health, MoHFW
Co-chair : Dr Pradeep Khasnobis, NPO, IDSP, NCDC
Two presentations were made in this session.
 Dr Saurabh Goel, Assistant Director, IDSP, NCDC highlighted that under
presumptive surveillance, currently 96% of districts and 84% of reporting units were
reporting on the IDSP portal. Challenges included—less representation from the
private sector; presumptive diagnosis not mentioned in the register by medical
officers; filling up of P Forms by pharmacists or even ward boys; difficulties in
extracting data for P Form from illegible OPD registers; no mechanisms to check
duplication of cases; limited capability to analyse data on state-specific diseases and
in correct recording of laboratory tests in the line list. He stressed that the new P & L
Forms could be designed based on reprioritization of diseases keeping in view
programme deliverables. The P Form based OPD registers should be revived at all
health facilities. More advanced specific data analysis tools should be integrated into
the portal. Provisioning of regular training of medical officers, sensitization of district
surveillance units (DSUs) and state surveillance units (SSUs) to analyse P Form data
and introduction of GIS into IDSP Portal were other steps that were needed.

 A presentation on “L Form Data on the IDSP portal” was made by Dr Lata Kapoor,
Joint Director, IDSP, NCDC. A line listing of positive cases in L Form, challenges in
filling up of L Form as well as solutions were stressed in her presentation. She also
highlighted additional diseases such as shigellosis, salmonellosis (non typhoidal),
scrub typhus and anthrax that were being proposed for L Form.

Key suggestions
 Reprioritization of diseases in L Form
 Line lists to be generated directly from computerized systems/Health Information
System (HIS)
 On-site data entry to prevent delays in reporting
 Cross notification of positive results tested in labs to get accurate geographical
disease trends
 Trends to be generated from line list data, not absolute numbers
 Analysis of line list at all levels for outbreak detection – laboratory, district and
state level

14
  For data captured through vertical programmes, avoid duplicate data collection
under IDSP establish IT enabled mechanisms to extract data needed for disease
surveillance under IDSP, e.g. vaccine preventable diseases (VPDs) and Vector
Borne Diseases.
 Unique Identity (UID) for each patient to avoid the same case being captured
more than once in the data.

3.3 Session 6: Information and communication technology

for IDSP
Session Chair : Dr Sujeet Kumar Singh, DDG, Mental Health & International Health, MoHFW
Co-chair : Dr Pradeep Khasnobis, NPO, IDSP, NCDC
Three presentations were delivered in this session.
Dr Suhas Dhandore, Assistant Director, IDSP, NCDC highlighted technical details like
overview of the IDSP Portal, data entry functionality, HR details, training status, master data
key functionality, IDSP dashboard and present status of IDSP portal.
Following was the proposed plan for upgradation of IDSP portal:
 Adoption of frameworks and standards to strengthen the HIS under IDSP
 Compliance to integrate e-governance standards in master data
 Revamping of IDSP portal to develop a GIS enabled software application, mobile
technology for real time data collection and integration of SMS gateway and
automated e-mail alerts
 Introducing basic and advanced web analytical features in the portal
 Redesigning of portal output, development of dashboard for real time
visualization of data
 Decentralization of data entry up to health facility level
 Development of offline data entry module
 Interoperability of application for automated sharing of data among other MIS
applications of disease control programmes.
A presentation on “An architectural approach to updating IDSP’s Integrated Disease
Surveillance Information System” was delivered by Dr Ramesh S. Krishnamurthy, Senior
Advisor, Health Systems and Innovation Cluster, WHO, Geneva. Two key factors for
architectural approach – minimum data sets and appropriate use of standards-based ICT
interventions were stressed.
Following components were highlighted for updating IDSP’s Information System:

 Resources (leadership, policies, financial and human resources, infrastructure)

 Indicators (morbidity, mortality, environmental risks, health resources availability
and readiness, vaccine coverage)
 Data sources (common operational datasets, health facilities data, reports from
subnational health management teams and coordination meetings, health
workforce, human and animal surveillance, laboratories, data on stockpiles of
medicines and commodities, financial data, etc.)

15
  Data management (collection, storage, quality assurance, processing,
compilation, analysis and visualization of data and geospatial information
presentation)
 A collaborative platform for information sharing
 Information products (situation reports, 3Ws (who does what, where and when),
case summary statistics, media/communication reports, financial reports, health
workforce distribution reports, etc.)

Phase-based upgrading of IDSP’s information system was suggested at all levels. Following
are the recommendations for updating the IDSP’s Integrated Disease Surveillance
Information System:
Information systems and ICT:
 Develop or update
– Comprehensive information management master plan document
– Comprehensive operations plan document to include data and information needs
related to all activities and functions of IDSP at central and state levels
– Update IDSP portal
– Upgrade Central Surveillance Unit (CSU)’s information platform
– Upgrade ICT of CSU’s strategic health operations centre (SHOC)
 Fully upgrade information systems and ICT infrastructure for SHOC at Central, state,
and large municipality levels
 Data for disease surveillance: Update the following components for all diseases that
are prioritized:
– Case definition
– Surveillance type
– Surveillance data sets
– Surveillance data collection standards
– Adjust all reporting forms (P, L) to reflect the aforementioned components
 Data display and visualization
– Design dashboard frame and its essential components
– Identify surveillance data from other programmes/activities within the MoHFW for
potential display in a common integrated disease surveillance dashboard
– Develop agreements to obtain data from other programmes/activities and
demonstrate a prototype dashboard
 Data sharing agreements
Data-sharing agreements need to be put in place between various parties, including states,
local governments and the private sector and all data sharing agreements must be updated.
Bruhat Bengaluru Mahanagara Palika (BBMP) experiences in software for IDSP were
shared by Dr M.N. Lokesh, Chief Health Officer (Public Health), BBMP focusing on software
application of BBMP – Public Health Information and Epidemiological Cell (PHIEC).
Following are the key features of the software:
– Online data collection
– Data collection from government and private hospitals

16
 – Line listing of patients with GIS location
– SMS/e-mail alerts to MoHFW for confirmed cases
– Update from rapid response teams in the field
– Weekly reporting and emergency reporting
– Data on noncommunicable diseases and Syndromic Surveillance Form (S Forms)
– Outbreak/media alerts, VPD alerts
– Reports for MoHFW and epidemiologists
– Reports, charts on map
– “Thank you” e-mail, reminder SMS
– Hospitals in BBMP area that are GIS mapped
– Over 350 private hospitals given access to the application
– MoHFW and Health Officers have access to dashboards
– Auxiliary nurse midwives (ANMs) and health inspectors trained to update in the
field for control and preventive actions.
Mr Lav Agarwal, JS, MoHFW appreciated the architectural approach for updating IDSP‘s
information system as well as BBMP’s software experience on IDSP.

3.4 Session 7: Recommendations and conclusions

Session Chair : Dr B.D. Athani, Special DGHS, MoHFW
Co-chair : Dr S. Venkatesh, Director, NCDC.
3.4.1 Key recommendations
 The reprioritization workshop identified 32 conditions as per weighted scores in a
rank order of importance. However, apart from the 32 diseases, there was consensus
among the experts to also include human rabies into the list.
 IDSP needs to update the following components for all diseases that are prioritized
through the consultative process: case definitions; type of surveillance to be
implemented for each prioritized disease; and minimum data sets and data collection
standards for each prioritized disease. It also needs to make all relevant changes to
the reporting forms to reflect the amendments.
 IDSP may advice all state SSUs to conduct similar reprioritization exercises to
include diseases of importance at the state level.
 IDSP’s ICT platform and information management need to be upgraded to conform to
the current standards. A comprehensive ICT and Information Management Master
Plan document needs to be developed and maintained. The ICT Master Plan
component needs to clearly define the computer network architecture at CSU level
(including the data layer and application layer) while the information management
document must contain all aspects of data management, including data privacy and
confidentiality at both CSU and SSU levels.
 Two-level information architecture needs to be considered for disease surveillance
management. Level-1 architecture should exclusively address the data and
information exchange needs at the CSU level and give a clear articulation of the
revised IDSP portal as well as the needs of Strategic Health Operations Centre.
Level 2 architecture should address the data and information exchange at the SSU
levels. Near real-time data collection approaches as well as advanced data analytics
and visualization techniques must be considered as part of the architecture. A

17
 comprehensive Operational Document has to be developed to implement the
aforementioned Master Plan with clearly articulated timelines, roles and
responsibilities.
 Manage the IDSP data and information systems without interruption. Data sharing
agreements need to be put in place between various parties, including state and local
government levels and the private sector and all data sharing agreements must be
updated.
 IDSP needs to identify all relevant disease surveillance aggregate data from
specialized disease surveillance programmes for potential inclusion under a common
integrated disease surveillance dashboard that will be administered by IDSP.
In his concluding remarks, Dr S. Venkatesh, Director, NCDC expressed his appreciation to
the participants for their efforts in prioritizing the diseases.
In his closing remarks, Dr B. D. Athani, Special DGHS, MoHFW expressed his appreciation
for the successful organization of this workshop. Dr Pradeep Khasnobis, NPO, IDSP, NCDC
thanked all the participants for their active involvement in the workshop and dignitaries for
their guidance in successful organization of the workshop.

18
Annexures
Annexure 1: Agenda

Day 1 – 06 December 2016

Inaugural session: 10:00–11:00

Welcome address by Dr S. Venkatesh, Director, NCDC, MoHFW

Introduction of participants

Address by Mr Lav Agarwal, Joint Secretary, MoHFW

Address by Mr Sanjeeva Kumar, Additional Secretary, MoHFW

Address by Dr Henk Bekedam, WHO Representative, India

Address by Dr B.D. Athani, Special DGHS, MoHFW

Special Address by Professor (Dr) Jagdish Prasad, Director General of Health

Services, MoHFW

Vote of Thanks by Dr Pradeep Khasnobis, NPO, IDSP, NCDC

Session 1: 11:00–12:00 – Trends in surveillance systems and current status of

IDSP
Chair: Dr B.D. Athani, Special DGHS, MoHFW
Co-chairs: Dr A. K. Gadpayle, Addl. DGHS, MoHFW and Dr K. K. Aggarwal,
President-elect, Indian Medical Association
Integrated disease surveillance programme (10 mins): Dr Pradeep Khasnobis,
NPO, IDSP, NCDC
Surveillance review from GHSA in India (10 mins): Dr Sameer Sodha, CDC
Resident Advisor, Epidemic Intelligence Service Programme, India

Surveillance models of Sri Lanka and Thailand (10 mins): Dr Vason Pinyowiwat,
Technical Officer, WHO Regional Office for South-East Asia

Why disease prioritization of IDSP – the past and current status (10 mins): Dr
Nishant Kumar, Assistant Director, IDSP, NCDC
Diseases under consideration for IDSP (10 mins): Dr Sanket V. Kulkarni,
Assistant Director, IDSP, NCDC

Discussion and wrap-up (10 mins)

19
Session 2: 12:00–01:00 – Disease prioritization
Chair: Dr S. Venkatesh, Director, NCDC, MoHFW
Co-chair: Dr Ramesh Krishnamurthy, Senior Advisor, Department of Information,
Evidence and Research, Health Systems and Innovation Cluster, WHO
Disease prioritization methodology (30 mins): Dr Giridhara R. Babu, Additional
Professor, Indian Institute of Public Health, Bengaluru

Instructions for group work and sample scoring exercise (15 mins): Dr Giridhara
R. Babu, Additional Professor, Indian Institute of Public Health, Bengaluru

Discussion and wrap up (10 mins)

Lunch break – 01:00–02:00

Session 3: 02:00–05:30 – Disease prioritization

Chair: Dr S. Venkatesh, Director, NCDC, MoHFW
Co-chair: Dr Ramesh Krishnamurthy, Senior Advisor, Department of Information,
Evidence and Research, Health Systems and Innovation Cluster, WHO
Formation of groups and ground rules for scoring (10 mins)
Group work on disease prioritization (180 mins)

Tea Break: 03:30–03:40

Discussion and wrap up (10 mins)

Day 2 – 07 December 2016

Session 4: 09:00–12:00 – Presentation of findings and panel reflections
Chair: Dr P.L. Joshi, Ex Director, NVBDCP, MoHFW
Co-chairs: Dr D.C.S. Reddy, Ex Professor and Head, Department of Preventive
and Social Medicine, Institute of Medical Sciences, Banaras Hindu University and
Dr Pavana Murthy, National Professional Officer, Surveillance and Response,
WHO Country Office for India
Presentation of group work (15 mins per group): Rapporteurs of working groups

Panel reflection (30 mins)

Tea Break: 11:00–11:15

Finalization of list of prioritized diseases (30 mins): Dr Pradeep Khasnobis, NPO

IDSP, NCDC and Dr Pavana Murthy, National Professional Officer, Surveillance
and Response, WHO Country Office for India
Wrap up (15 mins): Dr Pavana Murthy, National Professional Officer, Surveillance
and Response, WHO Country Office for India

20
Session 5: 12:00–01:00 – Data collection tools for IDSP
Chair: Dr Sujeet Kumar Singh, DDG, Mental Health & International Health, MoHFW
Co-chair: Dr Pradeep Khasnobis, NPO, IDSP, NCDC
P&L Forms (30 mins): Dr Lata Kapoor, Joint Director, IDSP, NCDC and Dr
Saurabh Goel, Assistant Director, IDSP, NCDC

Short, medium and long term plans (30 mins): Plenary discussion

Lunch break: 01:00–02:00

Session 6: 02:00–03:30 – Information and communication technology for IDSP

Chair: Dr Sujeet Kumar Singh, DDG, Mental Health & International Health, MoHFW
Co-chair: Dr Pradeep Khasnobis, NPO, IDSP, NCDC

IDSP Information communication and portal: Dr Suhas Dhandore, Assistant

Director, IDSP, NCDC (30 mins)

Information systems for IDSP – minimum data sets (30 mins): Dr Ramesh
Krishnamurthy, Senior Advisor, Department of Information, Evidence and
Research, Health Systems and Innovation Cluster, WHO

Bruhat Bengaluru Mahanagara Palika (BBMP) experiences in software for IDSP

(30 mins): Dr M.N. Lokesh, Chief Health Officer (Public Health), BBMP, Bengaluru

Tea break: 03:30–03:45

Session 7: 03:45–05:00 – Recommendations and conclusions

Chair: Dr B.D. Athani, Special DGHS, MoHFW
Co-chair: Dr S. Venkatesh, Director, NCDC, MoHFW

Recommendations
Dr Pavana Murthy, National Professional Officer, Surveillance and Response,
WHO Country Office for India

Concluding remarks
Dr S. Venkatesh, Director, NCDC, MoHFW
Dr B.D. Athani, Special DGHS, MoHFW
Vote of thanks
Dr Pradeep Khasnobis, NPO, IDSP, NCDC

21
Annexure 2: List of participants
Professor A.C. Phukan Dr Ananya Ray Laskar
Head of the Department Microbiology Assistant Director, National Centre for
& I/c A.I. Laboratory Disease Control
North Eastern Indira Gandhi Regional New Delhi
Institute of Health and 9811178028
Medical Sciences, Shillong ananya.ray.laskan@gmail.com
9402196194
dranilphukan@yahoo.co.in Dr Anil V.
Assistant Director (Public Health)
Dr A.K. Gadpayle Directorate of Health Services,
Additional Director General of Health Thiruvananthapuram, Kerala
services, Ministry of Health & Family 9846021483
welfare, Govt. of India, New Delhi anilvgovind@gmail.com
986888188
akgadpayle@yahoo.co.in Dr Arghya Pradhan
State Surveillance Officer
Dr Aakash Shrivastava Odisha
Sr. Chief Medical Officer, 9439994857
National Centre for Disease Control arghyap1@gmail.com
New Delhi
1123913148 Dr Arindam Ray
dr.aakash.shrivastava@gmail.com Country Lead, New Vaccines and
Immunization Systems,
Dr Ajay Kumar Bill & Melinda Gates Foundation
Consultant, Integrated Disease New Delhi
Surveillance Programme, National Centre 919643107480
for Disease Control
New Delhi Dr Arti Bahl
9968275024 Joint Director
idsp-dpa@nic.in National Centre for Disease Control
New Delhi
Dr A.K. Pandey artichitkara@rediffmail.com
State Surveillance Officer
Uttar Pradesh Ms Arunima Mukherjee
9454455490 Lead Health Systems,
Idspup@gmail.com Health Information Systems Programmes
New Delhi
Dr Amit Kumar Singh 9530707589
Scientist, Indian Council of Medical arunimam@gmail.com
Research
New Delhi Dr Balkrishna Sopan Kamble
8130108764 Assistant Director of Health Services,
dramit.icmr@gmail.com Pune, Maharashtra
9637117971
drbskamble@gmail.com

22
Dr B.D. Athani Dr C.S. Aggarwal
Special Director General of Additional Director
Health Services National Centre for Disease Control
Ministry of Health and Family Welfare csaggarwal@yahoo.co.in;
New Delhi epiddiv@gmail.com
011-23061467
bd.athani56@nic.in Dr C.S. Moghe
Epidemic Intelligence Service Officer
Dr B.P. Dutta New Delhi
Epidemic Intelligence Service Officer c_moghe@rediffmail.com
New Delhi
dutta_bp@rediffmail.com Dr D.C.S. Reddy
Ex-Professor and Head of the
Dr B. Virumbi Viduthalai Department, Department of Social and
Scientist D Preventive Medicine
National Institute of Epidemiology Institute of Medical sciences,
Chennai Banaras Hindu University
9894726160 9559736368
vvirumbi@nieicmr.org.in reddydcs@gmail.com
massphp@gmail.com
Dr Deepak Kumar
Dr Charan Singh Dy Surv Team Leader
Director National Polio Surveillance Unit, WHO
Rural Health Training Centre Country Office for India
Najafgarh, New Delhi kumarde@who.int
9654100345
rhtcnajafgarh@gmail.com; Dr Dipu Lowang
charan688@gmail.com Epidemic Intelligence Service Officer
New Delhi
Dr Chhavi Pant Joshi lowangd@ymail.com
Deputy Assistant Director General
(Environmental Health), Directorate Dr Dinkar Raval
General of Health Services Ministry of Deputy Director (Epidemic)
Health & Family welfare, New Delhi Commissionerate of Health
9871006992 Gandhinagar, Gujarat
drchhavipant@gmail.com 9909966905
dr.dinkar@outlook.com
Dr Chinmayee Das
Deputy Assistant Director General Dr Fareed Zafar
Directorate General of Health Services Epidemic Intelligence Service Officer
Ministry of Health & Family Welfare, New New Delhi
Delhi drfareeduzzafar@yahoo.in
9811911253
drchinmoyeedas@gmail.com

23
Dr G. Arunkumar Professor (Dr) Jagdish Prasad
Professor and Head, Manipal Centre for Director General of Health Services
Virus Research, Ministry of Health and Family Welfare,
Manipal Centre for Virus Research, Govt. of India, New Delhi
Manipal University, Manipal 011-23061063
9845584163 dghs@nic.in
arun.kumar@manipal.edu
Dr Jyoti
Dr Giridhara R. Babu Assistant Director, IDSP, National Centre
Additional Professor for Disease Control, New Delhi
Indian Institute of Public Health, 9871787984
Bengaluru campus, Bengaluru jyoti.idsp@gmail.com
9845036197
epigiridhar@gmail.com Dr Kayla Laserson
Country Director, Division of Global Health
Dr G.K. Durairaj Protection,
Ex-Additional Director Centre for Disease Control and Prevention
Directorate of Public Health & Preventive (CDC), New Delhi
Medicine, Chennai, Tamil Nadu 8826611772
9176393980 klaserson@cdc.gov

Dr Harsha Vardhan B. Dr K.K. Aggarwal

State Surveillance Officer, Karnataka President-elect,
9449843151 Indian Medical Association
ssubangalore@yahoo.co.in hsgima@gmail.com
ssuidspbangalore@gmail.com
Dr Lata Kapoor
Mr Haresh Patel Joint Director, IDSP,
Data Analyst National Centre for Disease Control
WHO Country Office for India New Delhi
New Delhi 9811214482
patelh@who.in idsp-lab@nic.in

Dr Henk Bekedam Mr Lav Agarwal

WHO Representative to India Joint Secretary
WHO Country Office for India Ministry of Health and Family Welfare
New Delhi Govt. of India, New Delhi
BekedamH@who.int 01123061195
9818778177
Mr Himanshu Sekhar Pradhan jslamohfw@gmail.com
Consultant, Surveillance
WHO Country Office for India Dr Leo Machado
9810185474 Training Focal Person, National Polio
himanshu.pradh@gmail.com Surveillance Unit,
WHO Country Office for India
machadol@who.int

24
Dr Madhup Bajpai Dr Nilesh Buddha
Regional Team Leader, Uttar Pradesh Technical Officer
National Polio Surveillance Programme WHO Regional Office for South East Asia
WHO Country Office for India New Delhi
9935545659 9958097017
rcup@ntsuindia.org buddhan@who.int
bajpaim@who.int
Dr Nishant Kumar
Dr Mahesh Waghmare Assistant Director, IDSP,
Assistant Director, National Centre for Disease Control
National Centre for Disease Control 9810965991
New Delhi dr.nishant@gov.in
9891117375
drmahesh108@gmail.com Dr Nivedita Gupta
Scientist E
Dr Meera Dhuria Indian Council of Medical Research,
Assistant Director New Delhi
National Centre for Disease Control 8447509008
New Delhi ngupta@icmr.org.in
miradhuria@gmail.com
Dr Padmini Shrikanth
Dr Meghna Desai Senior Medical Epidemiologist
National Polio Surveillance Programme Global Disease Detection Program- India
WHO Country Office for India US Centers for Disease Control and
New Delhi Prevention
New Delhi, India
Dr M.N. Lokesh Telephone: +91-88266-11774
Chief Health Officer (Public Health) Email: pks6@cdc.gov
Bruhat Bengaluru Mahanagara Palika
Bengaluru Dr P. Gunasekaran
9480683515, 9448242962 Director, King Institute of Preventive
drlokeshnagaraj@gmail.com Medicine and Research,
bbmpchopublichealth@gmail.com Chennai, Tamil Nadu
9840960225
Dr Mohan Papanna gunzking@gmail.com
Public Health Specialist
Centre for Disease Control and Prevention Dr Pankaj Bhatnagar
(CDC) National Professional Officer, WHO NPSP
New Delhi National Polio Surveillance Programme
8826020478 WHO Country Office for India
moi1@cdc.gov 9810189025
mpapanna@cdc.gov bhatnagarp@who.int

Dr Naveen Rastogi
Epidemic Intelligence Service Officer
New Delhi
drnaveen.rastogi@gmail.com

25
Dr Paul Francis Dr Prem Kumar
National Professional Officer, State Surveillance Officer, Tamil Nadu
Maternal and Child Health Directorate General of Health services
WHO Country Office for India, New Delhi Chennai
9818255387 Tamil Nadu
paulf@who.int 04464504990
9842252154
Dr Pavana Murthy tnssu.idsp@gmail.com
National Professional Officer, tnssu.idsp@nic.in
Surveillance and Response premkumar777@hotmail.com
WHO Country Office for India
New Delhi Dr Pranay Kumar Verma
8800797655 Assistant Director, IDSP,
murthyp@who.int National Centre for Disease Control
New Delhi
Dr P.K. Sen 9968694400
Additional Director pranay.verma@gov.in
National Vector Borne Disease Control
Programme (NVBDCP) Dr Prashanta Roy
New Delhi Regional Team Leader North, Delhi
9868127685 National Polio Surveillance Programme
nvbdcp.drpksen@gmail.com WHO country Office for India
New Delhi
Dr P.L. Joshi royp@who.int
Former Director,
National Vector Borne Disease Control Dr Prakin Suchaxaya
Programme Coordinator, Health Programme
New Delhi WHO Country Office for India
doctorjoshi00@gmail.com New Delhi
suchaxayap@who.int
Dr Pradeep Khasnobis
National Programme Officer, IDSP, Mr Prasun Sharma
National Centre for Disease Control Statistician-cum-Programmer
New Delhi Integrated Disease Surveillance
9868289921 Programme
idsp-cmo@nic.in National Centre for Disease Control,
New Delhi
Dr Pradeep Srivastava 011 23935532
Joint Director prasunshar@gmail.com
National Vector Borne Disease Control
Programme Dr Prasoon Shooran
9891494568 Epidemic Intelligence Service Officer
pkmalaria@yahoo.co.in, New Delhi
pradeepksrivastava@gmail.com prasoonsheoran@yahoo.com

26
Dr Praveen Ganganna Dr Ranjeet Prasad
Epidemiologist, Integrated Disease Epidemiologist, Integrated Disease
Surveillance Programme Surveillance Programme
National Centre for Disease Control, National Centre for Disease Control
New Delhi New Delhi
9899813856 rajdoct80@gmail.com
praveenidsp@gmail.com
Dr Ruchi Jain
Dr Raghvendra Kedlaya Assistant Director, IDSP,
IT Consultant, Bruhat Bengaluru National Centre for Disease Control
Mahanagara Palika 9350152512
Bengaluru ruchiidsp@gmail.com
9844318585
raghavendra@indigoinform.com Dr Sameer Sodha
CDC Resident Advisor
Dr Rajesh Yadav Epidemic Intelligence Service (EIS)
Public Health Specialist, Programme
Center for Disease Control and Centre for Disease Control And
Prevention (CDC), Prevention (CDC) , New Delhi
New Delhi 9599196428
8800628397 ssodha@cdc.gov
mdx5@cdc.gov
Dr Rajiv Tandon Dr Samiran Panda
Technical Director- Maternal, Newborn, Scientist F
Child Health, Nutrition and Adolescent National Institute of Cholera and Enteric
Health Diseases
PATH India Office, New Delhi Kolkata
9811103305 9830908475
rtandon@path.org andasamiran@gmail.com

Dr Rajul Gupta Dr Sanjeev Dalvi

Armed Force Medical College State Surveillance Officer
8527389090 Goa
rajulkgupta@yahoo.co.in 9011025033
gassu.idsp@nic.in
Dr Rakesh Roshan directorhealth_goa@yahoo.in
State Surveillance Officer, Himachal sfwbgoa@hotmail.com
Pradesh
9418485259; 7018989935 Dr Sanket V. Kulkarni
idspnhmhp@gmail.com Assistant Director, IDSP,
National Centre for Disease Control
Dr Ramesh S. Krishnamurthy New Delhi
Senior Advisor, Health Systems and 7836026688
Innovation Cluster sanket.kulkarni@gov.in
World Health Organization, Geneva
41798262472
Krishnamurthyr@who.int

27
Dr Saurabh Goel Ms Sujata Malhotra
Assistant Director, IDSP, Data manager,
National Centre for Disease Control Integrated Disease Surveillance
New Delhi Programme
9312660900 National Centre for Disease Control
8800511314
Dr Savitri G. idsp-dmit@nic.in
Joint Director/State Surveillance Officer &
State Programme Officer Dr Sujeet Kumar Singh
NVBDCP Deputy Director General (Mental Health &
Andhra Pradesh International Health Regulation)
9100108475 Ministry of Health and Family Welfare
idsp.ssuap@yahoo.co.in New Delhi
jdcdpap@gmail.com" 8130255553
sujeet647@gmail.com
Dr Siraj Ahmed Khan
Scientist E, RMRC Dr Suneet Kaur
Regional Medical Research Centre for Epidemiologist, IDSP,
North East Region National Centre for Disease Control,
Indian Council of Medical Research New Delhi
Dibrugarh, Assam drsuneet.idsp@gmail.com
03732381494
9435032866 Dr Sunil Gupta
sirajkhanicmr@gmail.com Additional Director & Head of the
Department, Microbiology,
Dr S.M. Raheja National Centre for Disease Control
Addl Director General ( Public Health)_ New Delhi
Directorate General of Health Services, 9810147553
Government of Delhi9718599009 sunil_guptadoc@yahoo.co.uk
drsmraheja@gmail.com
Dr S. Venkatesh
Dr Sudhir Joshi Director,
Certification & VPD surveillance Focal National Centre for Disease Control
person New Delhi
National Polio Surveillance Unit 011-23913148, 011-23946893
WHO country Office for India dirnicd@gmail.com
New Delhi
joshisu@who.int Dr Swati Chaudhary
Consultant Microbiologist,
Dr Suhas Dhandore National Centre for Disease Control
Assistant Director, IDSP, New Delhi
National Centre for Disease Control, drswatichaudhary.idsp@gmail.com
New Delhi
9818010235 Dr Syed Manzoor Kadri
suhas.dhandore@nic.in State Surveillance Officer
Srinagar, Kashmir
9419010363
kadrism@gmail.com

28
Dr Tanzin Dikid
Deputy Director,
National Centre for Disease Control
New Delhi
tanzindikid@gmail.com

Dr Vason Pinyowiwat
Technical Officer
WHO Regional Office for South East Asia
New Delhi
pinyowiwatv@who.int

29